Alginate Poly-L-Lysine microencapsulation of hMSC was performed as previously described (Maguire et al. 2007 (link)). The microencapsulated cells were re-suspended in MEM-α (Gibco) and transferred to 25 cm2 tissue culture flasks. Medium was changed every 7th day post-encapsulation for a total culture time of 21 days. In all experimental conditions, monolayer culture configurations of hMSC were used as controls for viability, growth kinetics, and functional studies. Microcapsules were synthesized with different concentrations of alginate (1.7%, 2.2% and 2.5%) as well as different initial cell densities (106, 2×106, 4×106 and 6×106 cells per ml). Based on initial viability post encapsulation, 4×106 cells per ml was identified to be optimal for MSC encapsulation and therefore used in all subsequent experiments (data not shown). Capsule diameters ranged from 450 to 550 μm for all in-vitro studies.
>
Chemicals & Drugs
>
Biomedical or Dental Material
>
Microcapsules
Microcapsules
Microcapsules are small, spherical capsules composed of a shell and a core.
The shell material may be made of polymers, lipids, or other materials, and the core can contain a variety of substances such as drugs, fragrances, or other active ingredients.
Microcapsules are used in a wide range of applications, including drug delivery, cosmetics, and food production.
Their small size and ability to protect and release their contents make them an important tool for researchers and industry professionals.
Microcapsules offer controlled release, targeted delivery, and improved stability for a variety of products and processes.
Their versatility and potential for innovation continue to drive advancements in this dynamic field of study.
The shell material may be made of polymers, lipids, or other materials, and the core can contain a variety of substances such as drugs, fragrances, or other active ingredients.
Microcapsules are used in a wide range of applications, including drug delivery, cosmetics, and food production.
Their small size and ability to protect and release their contents make them an important tool for researchers and industry professionals.
Microcapsules offer controlled release, targeted delivery, and improved stability for a variety of products and processes.
Their versatility and potential for innovation continue to drive advancements in this dynamic field of study.
Most cited protocols related to «Microcapsules»
Alginate
alginate-poly-L-lysine
Capsule
Cells
Kinetics
Microcapsules
Tissues
Microcapsules of PBUDCA and UDCA were prepared as established in our laboratory by Ionic Gelation Vibrational Jet Flow Technology, which utilises a Büchi encapsulator (Büchi Labortechnik, Flawil, Switzerland) under a constant liquid flow rate of 1 mL/min. The microcapsules were formed at 2% CaCl2 ionic gelation bath before being washed in water for a few minutes prior to collection and stability/shelf life assessed using Accelerated Stability Chambers using our well-established methods14 ,27 ,28 ,30 –33 . Microcapsule morphology and surface topography were examined using Micro-CT (a SkyScan 1172 A Micro-CT, Kontich, Belgium) and Zeiss-Neon 40EsB FIBSEM (USA) as per our well-established methods29 (link),70 . The surface characteristics were examined via FIB SEM (Zeiss Neon 40EsB, USA). Osmotic stability of the microcapsules was determined by placing 1 g of microcapsules in phosphate buffered saline for 14 days at 37 °C, and was calculated by weight gain attained compared to initial ‘dry’ weight14 ,27 ,28 . The mechanical resistance of the microcapsules was determined by placing 200 microcapsules in a shaker and vibrating them over 14 days, and the resistance index was calculated as percentage of damaged microcapsules to intact microcapsules30 ,34 . Microcapsules’ buoyancy was examined through placing 200 microcapsules in 200 mL of simulated intestinal fluids which consisted of enzyme-based phosphate buffer. The solution was stirred periodically at a set temperature 37.5 °C. The buoyancy index was calculated as the percentage of floating microcapsules3 . The heat resistance testing was performed by incubating 200 freshly made microcapsules in a climatic chamber (Angelantoni Environmental and Climatic Test Chamber, Italy) set at 37.5 °C for 14 days. The stability index was determined mathematically by calculating the percentage of undamaged microcapsules (no change in colour, texture, appearance or structural integrity) compared to pre-incubated fresh microcapsules3 ,11 (link),14 .
Full text: Click here
Bath
Buffers
Climate
Enzymes
Focused Ion Beam Scanning Electron Microscopy
Intestines
Ions
Microcapsules
Neon
Osmosis
Phosphates
Saline Solution
Ursodiol
Vibration
X-Ray Microtomography
The preparation of composite shells is a multistage process. The template for polymeric capsules were vaterite particles loaded with MNPs. Layer-by-layer assembly was used to make micron and submicron capsules35 (link),36 (link),44 (link). Microcapsules were prepared by sequential adsorption of 1 mL of BSA (concentration of 2 mg/mL in water) and tannic acid (concentration of 2 mg/mL in water) onto the spherical surfaces of CaCO3 cores. Every polymer adsorption cycle was conducted for 15 min. The cores were then gently dissolved by treatment with EDTA (concentration of 0.2 M in water, pH 7.3), and the residues were removed by two times washing in DI water. For gentle core dissolution, EDTA was slowly added to the particle suspension under shaking until the core disappeared. After each adsorption step, as well as after the dissolution of the CaCO3 cores, the suspension of the microparticles was centrifuged (at 240 g for micron capsules and at 1300 g for submicron capsules) and was washed twice with pure water42 (link). As a result, the capsules had shells with three bilayers of BSA–tannic acid. In contrast to vaterite particles, the polymeric composite capsules are very stable. All samples of composite capsules were kept in a freezer at 4 °C. After 15 months of storage, the capsules retained their shape and zeta potential (−45 ± 5 mV) and did not aggregate.
Full text: Click here
Adsorption
Capsule
Carbonate, Calcium
Cell-Derived Microparticles
Edetic Acid
Microcapsules
Polymers
Tannins
Vaterite
Acetone
Aluminum
Bath
Chloride, Ammonium
Emulsions
ethylene
ethylene-maleic anhydride copolymer
Formaldehyde
Light Microscopy
Maleic Anhydride
Microcapsules
Muscle Rigidity
resorcinol
Scanning Electron Microscopy
Sodium Hydroxide
Suby's G solution
Surface-Active Agents
triethylene glycoldimethacrylate
Urea
Vacuum
Six-week old, wild type (C57BL/6J) male mice were attained from the Animal Resources Centre (Australia). Mice were randomly allocated into seven groups, 10 each (n = 70). Group-1 was given low fat diet (LFD; healthy) and empty microcapsules, group-2 was given high fat diet (HFD; insulin-resistance) and empty microcapsules, group-3 was given HFD and metformin (200 mg/kg/day), group-4 was given HFD and low dose PB (80 mg/kg/day), group-5 was given HFD and high dose of PB (800 mg/kg/day), group-6 was given HFD and PBUDCA microcapsules (PB: 80 mg/kg/day and UDCA 70 mg/kg/day) and group-7 was given HFD and UDCA microcapsules (70 mg/kg/day). HFD consisted of AIN93M rodent chow enriched in 30% (w/w) lard, 0.5% (w/w) cholesterol and 15% (w/w) fructose (Specialty Feeds, Perth, Australia).
All mice were maintained on half-day dark cycle (22 °C) and with water and food ad libitum. At the end of 6-months experiment, mice were anaesthetized with isoflurane and euthanised by cardiac puncture followed by cervical dislocation. Blood was collected into EDTA tubes and stored on ice. Plasma was separated by short-speed centrifugation at 4 °C and stored at −80 °C. Tissues of different organs were removed at stored in 4% paraformaldehyde (PFA) at −80 °C. The animal experiments were approved by Curtin University Animal Ethics Committee and all experiments were performed according to the Australian Code of Practice for the care and use of animals for scientific purposes.
All mice were maintained on half-day dark cycle (22 °C) and with water and food ad libitum. At the end of 6-months experiment, mice were anaesthetized with isoflurane and euthanised by cardiac puncture followed by cervical dislocation. Blood was collected into EDTA tubes and stored on ice. Plasma was separated by short-speed centrifugation at 4 °C and stored at −80 °C. Tissues of different organs were removed at stored in 4% paraformaldehyde (PFA) at −80 °C. The animal experiments were approved by Curtin University Animal Ethics Committee and all experiments were performed according to the Australian Code of Practice for the care and use of animals for scientific purposes.
Full text: Click here
Animal Ethics Committees
Animals
BLOOD
Centrifugation
Cholesterol
Diet, High-Fat
Edetic Acid
Fat-Restricted Diet
Food
Fructose
Heart
Insulin Resistance
Isoflurane
Joint Dislocations
lard
Males
Metformin
Mice, House
Microcapsules
Neck
paraform
Plasma
Punctures
Rodent
Tissues
Ursodiol
Most recents protocols related to «Microcapsules»
Example 5
According to the teachings herein, one or more peptides comprising a lipoprotein targeting domain and a protease inhibitor domain, optionally further including therebetween a linker, can be placed in a suitable container, such as a tissue microcapsule implant, and placed within a subject to allow continuous, slow release of one or more of the disclosed peptides. Such peptides can either be provided in the free state or after complexation with lipid (e.g., in the form of a loaded or enriched nHDL or rHDL).
Full text: Click here
Lipids
Lipoprotein (a)
Lipoproteins
Microcapsules
Peptides
Protease Inhibitors
SERPINB5 protein, human
Teaching
Tissues
Protocol full text hidden due to copyright restrictions
Open the protocol to access the free full text link
Acetone
Animals
Biological Assay
Biopharmaceuticals
Cell Survival
Cytotoxin
Enzyme-Linked Immunosorbent Assay
Factor XII
Fingers
fluorexon
Gossypium
hexamethyldisiloxane
L929 Cells
Lactate Dehydrogenase
Males
Microcapsules
Obstetric Delivery
prothrombin fragment 1.2
Rats, Sprague-Dawley
sodium silicate
Sulfuric Acids
Temperature Regulations, Body
16.00 g P1000, 4.00 g CD-MDI, and 1.05 g polyurethane polyurea bilayer STF microcapsules were mixed and stirred for 2 min by a planetary stirrer. It was poured into a Teflon mold and cured at room temperature for 24 h, followed by curing in an oven at 60 °C for 24 h to give a 1 mm thick composite polyurea material (PM-STF-PUA). The preparation method of pure polyurea sample was consistent with the above method but the microcapsule addition amount was 0%.
Fungus, Filamentous
Microcapsules
polyurea
Polyurethanes
Teflon
31 g nanosilica, 19 g polyethylene glycol, and 50 g absolute ethanol were mixed and stirred for 10 min by a planetary stirrer. After drying in a vacuum oven to remove absolute ethanol and deformation by ultrasonication for 30 min, STF was obtained. Then, 1.00 g STF, 18.75 g liquid paraffin, and 0.10 g Span80 were mixed and stirred for 10 min with a magnetic bar at 800 rpm to obtain an emulsion. After adding 10 μL dibutyltin disilicate and 0.1 mL carbodiimide-modified 4,4′-diphenylmethane diisocyanate, the emulsion was stirred for 10 min. After the above steps, 0.05 mL diethylenetriamine was added to the reaction solution, and the mixture was stirred for 5 min. After this, the mixture was washed with toluene three times, followed by drying in a vacuum oven at 60 °C for 8 h to obtain polyurea polyurethane bilayer STF microcapsules.
4,4'-diphenylmethane diisocyanate
Carbodiimides
dibutyltin
diethylenetriamine
Emulsions
Ethanol
Microcapsules
Oil, Mineral
Polyethylene Glycols
polyurea
Polyurethanes
Toluene
Vacuum
As shown in Fig. 1 , the preparation of the dual shell microcapsules includes three steps. Firstly, a micron-sized emulsion was firstly obtained after stirring the mixture of STF, liquid paraffin, and Span80 (as emulsifier) at a low rotation speed (Fig. 1(a) ). Then, the polycondensation occurs between the PEG in the STF droplets and CD-MDI at the surface of the emulsion to form a preliminary polyurethane shell layer (Fig. 1(b) ). Finally, the unreacted isocyanate on the surface of polyurethane shell layer reacts with DETA to form a dense polyurea shell layer (Fig. 1(c) ). As a result, dual shell microcapsules are formed.
The dispersed particles adopted for the preparation of STF are solid silica microspheres with a particle size of about 150 nm, which plays a decisive role in the shear thickening performance of STF, as shown inFig. 1(e) . To investigate the shear thickening property of the STF, the rheological tests of STF with different silica concentrations are carried out (details in ESI† ). As shown in Fig. 1(f) , the viscosity of SiO2/PEG200 fluids firstly decreases with the increase in the shear rate, then increases rapidly after a critical shear rate is reached. The higher the concentration of silica, the lower the critical shear rate and the faster the viscosity mutation. When the concentration of silica is 68.5%, after a critical shear rate at 60 s−1 was reached, the viscosity increases rapidly and the value at the peak was 28 times larger than the initial value. To make sure that STF can be suspended in the solvent, the STF with lower concentration (62.0%) is chosen. Nevertheless, the consumption of PEG during the following reaction process will increase the concentration of silica, which ensures the good shear thickening performance (details in ESI† ). This ingenious design not only ensures the dispersion of STF but also maintains good shear thickening performance.
The emulsification effect of STF in liquid paraffin was observed by optical microscopy and the prepared double-layered microcapsules, and the cross-sections of composites were observed by SEM, as shown inFig. 2(a) . It can be seen from Fig. 2(a1) and (a4) that STF emulsification in liquid paraffin is well dispersed. The average droplet diameter is 100 μm with an agitation rate of 800 rpm. As shown in Fig. 2(a2) and (a3) , the spherical particle size and double layered microcapsule wall are 190 μm and 14.31 μm, respectively. The surface of the microcapsules has a certain roughness, which is believed to be caused by the uneven shrinkage of wall materials caused by the rapid evaporation of solvent in the drying process and the certain adhesion between microcapsules in the emulsion reaction. We also used drop addition to prepare STF capsules for comparison (details in ESI† ).
To investigate the structure of the core material, pure wall material, and microcapsules, the FTIR test was carried out, and the results are shown inFig. 2(b) . The peak at 1082 cm−1 corresponds to the asymmetric and symmetric vibrations of the Si–O–Si groups of the silica microspheres in the core material STF, which could also be observed in the spectra of the microcapsules. In the spectra of b2 and b3, the carbonyl peaks in the range of 1646–1543 cm−1 and the peak of the stretching vibration of –NH at 3279 cm−1 are observed. The same absorption peak also appears in the spectra of microcapsules, which confirms the formation of polyurea and polyurethane. By comparing the spectra of b3 and b4, the microcapsules and polyurea have the same characteristic absorption peaks at 2922 cm−1 and 2854 cm−1, which further indicates that the outermost layer of the microcapsules is the polyurea shell. According to the infrared spectrum, the absorption characteristic peaks of the STF and the polyurea-polyurethane shell can be observed, which confirms the successful encapsulation of STF within the microcapsules.
Besides, the thermogravimetric analysis of the double-layered microcapsules, pure core material, and pure wall material are shown inFig. 2(c) . According to Fig. 2(c1) , the STF shows only one thermal degradation stage from 150 °C to 370 °C, which corresponds to the thermal decomposition process of the PEG contained in it. The weight of the pure core material (STF) decreases rapidly at 225 °C. In comparison, the microcapsule with STF as the core shows two weight loss stages (Fig. 2(c4) ), indicating the successful encapsulation of STF in the PU/PUA shell. Moreover, the initial decomposition temperature of the microcapsule is quite close to that of the STF, which indicates that the weight loss of the first stage at 240 °C mainly arises from the volatilization and decomposition of the STF. By comparing Fig. 2(c2–c4) , it clearly shows that the decomposition temperature of the polyurethane shell and polyurea shell is 320 °C, proving that the core material has a good coating effect under PU and PUA shell. Compared to Fig. 2(c1) , the thermal weight loss temperature point of STF in microcapsule increases from 225 °C to 240 °C and the weight loss speed of STF slows down. This indicates that the polyurea polyurethane double-layered microcapsules have good thermal protection to the core material. The polyurea polyurethane shell can not only improve the service temperature of STF but also slows down the leakage of STF.
The dispersed particles adopted for the preparation of STF are solid silica microspheres with a particle size of about 150 nm, which plays a decisive role in the shear thickening performance of STF, as shown in
The emulsification effect of STF in liquid paraffin was observed by optical microscopy and the prepared double-layered microcapsules, and the cross-sections of composites were observed by SEM, as shown in
To investigate the structure of the core material, pure wall material, and microcapsules, the FTIR test was carried out, and the results are shown in
Besides, the thermogravimetric analysis of the double-layered microcapsules, pure core material, and pure wall material are shown in
Capsule
DEET
Emulsions
Light Microscopy
Microcapsules
Microspheres
Mutation
Oil, Mineral
polyurea
polyurethane isocyanate
Polyurethanes
Silicon Dioxide
Solvents
Spectroscopy, Fourier Transform Infrared
Vibration
Viscosity
Vision
Volatilization
Top products related to «Microcapsules»
Sourced in United Kingdom, Germany, France, United States, Canada
The Mastersizer 2000 is a laser diffraction particle size analyzer that measures the size distribution of particles in a sample. It uses the principle of laser light scattering to determine the particle size distribution of materials in the range of 0.1 to 2000 microns.
Sourced in Switzerland, Germany, Italy
The Mini Spray Dryer B-290 is a laboratory equipment designed for spray drying applications. It uses a two-fluid nozzle to atomize the feed material into fine droplets, which are then dried in a stream of hot air. The Mini Spray Dryer B-290 is a compact and versatile unit suitable for a wide range of applications, including the production of powders, granules, and microencapsulated particles.
Sourced in Japan, United States, China, Germany, United Kingdom, Spain, Canada, Czechia
The S-4800 is a high-resolution scanning electron microscope (SEM) manufactured by Hitachi. It provides a range of imaging and analytical capabilities for various applications. The S-4800 utilizes a field emission electron gun to generate high-quality, high-resolution images of samples.
Sourced in Japan, Germany, United States, China
The SU8010 is a field emission scanning electron microscope (FE-SEM) manufactured by Hitachi. It is designed for high-resolution imaging of a wide range of sample types. The SU8010 provides stable and reliable performance, with a high-resolution capability and a wide range of analytical functions.
Sourced in United States, United Kingdom, Germany, Canada, Spain
The LS 13 320 is a laser diffraction particle size analyzer manufactured by Beckman Coulter. It is designed to measure the size distribution of particles in a sample, ranging from 0.017 to 2000 microns in diameter.
Mowiol® KL-318 is a polyvinyl alcohol (PVOH) product manufactured by Kuraray. It is a water-soluble, biodegradable polymer with specific molecular weight and viscosity characteristics. The core function of Mowiol® KL-318 is to serve as a raw material or additive in various industrial and commercial applications.
Sourced in United Kingdom, Germany, United States, France
The Mastersizer 3000 is a laser diffraction particle size analyzer that measures the size distribution of particles in a sample. It utilizes the principle of light scattering to determine particle size, providing detailed information about the particle size characteristics of a wide range of materials.
Sourced in United Kingdom, Germany, United States, France, Japan, China, Netherlands, Morocco, Spain, Cameroon
The Zetasizer Nano ZS is a dynamic light scattering (DLS) instrument designed to measure the size and zeta potential of particles and molecules in a sample. The instrument uses laser light to measure the Brownian motion of the particles, which is then used to calculate their size and zeta potential.
Sourced in Switzerland, Germany, United States
The B-290 is a laboratory equipment designed for evaporation and drying applications. It features a compact design and advanced temperature control capabilities.
Sourced in United States, Germany, United Kingdom, Italy, India, China, France, Spain, Poland, Canada, Israel, Saudi Arabia, Sao Tome and Principe, Czechia, Switzerland, Denmark, Macao, Taiwan, Province of China, Australia, Brazil, Singapore
Sodium alginate is a naturally-derived, water-soluble polysaccharide that is commonly used as a thickening, stabilizing, and gelling agent in various laboratory applications. It is extracted from brown seaweed and is known for its ability to form viscous solutions and gels when combined with water. Sodium alginate is a versatile material that can be utilized in a range of laboratory procedures and formulations.
More about "Microcapsules"
Microcapsules, also known as microparticles or microspheres, are small, spherical capsules composed of a shell and a core.
The shell material may be made of polymers, lipids, or other materials, while the core can contain a variety of substances such as drugs, fragrances, or other active ingredients.
These tiny, versatile capsules are used in a wide range of applications, including drug delivery, cosmetics, and food production.
One of the key benefits of microcapsules is their ability to protect and release their contents in a controlled manner.
This makes them an important tool for researchers and industry professionals, as they offer improved stability, targeted delivery, and controlled release for a variety of products and processes.
The Mastersizer 2000, Mini Spray Dryer B-290, S-4800, SU8010, LS 13 320, and Mastersizer 3000 are some of the instruments used to analyze and characterize microcapsules.
Microcapsules are also used in the production of Mowiol® KL-318, a water-soluble polymer that can be used as a binder, thickener, or film-forming agent.
The Zetasizer Nano ZS is an instrument commonly used to measure the size and zeta potential of microcapsules, which are important properties for understanding their behavior and performance.
Advances in microcapsule technology continue to drive innovation in fields such as drug delivery, where they can be used to improve the bioavailability and stability of pharmaceuticals.
The versatility and potential of microcapsules make them an exciting area of study, with ongoing research aimed at developing new applications and improving existing ones.
The shell material may be made of polymers, lipids, or other materials, while the core can contain a variety of substances such as drugs, fragrances, or other active ingredients.
These tiny, versatile capsules are used in a wide range of applications, including drug delivery, cosmetics, and food production.
One of the key benefits of microcapsules is their ability to protect and release their contents in a controlled manner.
This makes them an important tool for researchers and industry professionals, as they offer improved stability, targeted delivery, and controlled release for a variety of products and processes.
The Mastersizer 2000, Mini Spray Dryer B-290, S-4800, SU8010, LS 13 320, and Mastersizer 3000 are some of the instruments used to analyze and characterize microcapsules.
Microcapsules are also used in the production of Mowiol® KL-318, a water-soluble polymer that can be used as a binder, thickener, or film-forming agent.
The Zetasizer Nano ZS is an instrument commonly used to measure the size and zeta potential of microcapsules, which are important properties for understanding their behavior and performance.
Advances in microcapsule technology continue to drive innovation in fields such as drug delivery, where they can be used to improve the bioavailability and stability of pharmaceuticals.
The versatility and potential of microcapsules make them an exciting area of study, with ongoing research aimed at developing new applications and improving existing ones.